drugset / Trial / NCT00708994

Cannabinoids, Neural Synchrony, and Information Processing

NCT00708994

RandomizedCrossoverQuadruple-blindBasic science

Summary

The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), the principal active ingredient of cannabis, on neural synchrony. Neural synchrony is studied using electroencephalography (EEG).

Timeline

Start
2008-02-25
Primary completion
2012-12-03
Completion
2012-12-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator delta-9-tetrahydrocannabinol Other / unclassified 0.0015 mg/kg Intravenous
Comparator delta-9-tetrahydrocannabinol Other / unclassified 0.015 mg/kg Intravenous
Comparator delta-9-tetrahydrocannabinol Other / unclassified 0.03 mg/kg Intravenous

Indications